Evidence map›Paper›PMID 20870965›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Transgenic rhesus monkeys produced by gene transfer into early-cleavage-stage embryos using a simian immunodeficiency virus-based vector.

Yuyu Niu, Yang Yu, Agnieszka Bernat, Shihua Yang, Xiechao He, Xiangyu Guo, Dongliang Chen, Yongchang Chen, Shaohui Ji, Wei Si and 12 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Liver-specific transgenic expression of human NTCP in rhesus macaques confers HBV susceptibility on primary hepatocytes.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Science advances · 2022
    Article
  15. Review
  16. Review
  17. Article
  18. Gene editing monkeys: Retrospect and outlook.Frontiers in cell and developmental biology · 2022
    Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 9 institutions in 5 countries.

Yuyu NiuKunming Primate Research Center and Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, People's Republic of China.
Yang Yu
Agnieszka Bernat
Shihua Yang
Xiechao He
Xiangyu Guo
Dongliang Chen
Yongchang Chen
Shaohui Ji
Wei Si
Yongqin Lv
Tao Tan
Qiang Wei
Hong Wang
Lei Shi
Jean Guan
Xuemei Zhu
Marielle Afanassieff
Pierre Savatier
Kang Zhang
Qi Zhou
Weizhi Ji
Kunming Institute of Zoology · CNChinese Academy of Sciences · CNInstitut National de Recherche en Santé Publique · MLUniversity of California, San Diego · USYunnan Yingmao Biotechnology (China) · CNInstitut Cellule Souche et Cerveau · FRInstitute of Zoology · CNKunming University of Science and Technology · CNSichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of transgenic technologies in monkeys is important for creating valuable animal models of human physiology so that the etiology of diseases can be studied and potential therapies for their amelioration may be developed. However, the efficiency of producing transgenic primate animals is presently very low, and there are few reports of success. We have developed an improved methodology for the production of transgenic rhesus monkeys, making use of a simian immunodeficiency virus (SIV)-based vector that encodes EGFP and a protocol for infection of early-cleavage-stage embryos. We show that infection does not alter embryo development. Moreover, the timing of infection, either before or during embryonic genome activation, has no observable effect on the level and stability of transgene expression. Of 70 embryos injected with concentrated virus at the one- to two-cell stage or the four- to eight-cell stage and showing fluorescence, 30 were transferred to surrogate mothers. One transgenic fetus was obtained from a fraternal triple pregnancy. Four infant monkeys were produced from four singleton pregnancies, of which two expressed EGFP throughout the whole body. These results demonstrate the usefulness of SIV-based lentiviral vectors for the generation of transgenic monkeys and improve the efficiency of transgenic technology in nonhuman primates.

Indexed as

Gene Transfer TechniquesModels, AnimalAnimalsAnimals, Genetically ModifiedBlotting, SouthernCleavage Stage, OvumDNA PrimersFemaleFlow CytometryFluorescent DyesGenetic VectorsGreen Fluorescent ProteinsImmunohistochemistryMacaca mulattaPolymerase Chain ReactionPregnancyDNA Primersenhanced green fluorescent proteinFluorescent DyesGreen Fluorescent Proteins

Identifiers

PMID20870965
PMCPMC2955145
OpenAlexW1999453796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.